Exercise Training in Patients With Atrial Fibrillation (OPPORTUNITY Study)
1 other identifier
interventional
94
1 country
1
Brief Summary
Atrial fibrillation is the most common heart rhythm disorder. The management of atrial fibrillation is of great importance. Despite the presence of exercise intolerance, weight gain, and an associated decline in overall health and well-being in patients living with atrial fibrillation, recommended standard care does not currently include the prescription of exercise to address these significant health issues. Exercise training is a recognized form of treatment of persons with heart disease. An exercise program such as high-intensity interval training when compared to moderate-intensity continuous exercise training may provide a stronger training stimulus for exercise and clinical outcomes; may be more efficient and motivating; and, may help to improve adherence to exercise training in persistent or permanent atrial fibrillation patients. This has been shown in patients with coronary artery disease and heart failure. The primary objectives of this prospective study are to examine the impact of high-intensity interval training compared to moderate-intensity continuous exercise training in adults with persistent or permanent atrial fibrillation on exercise capacity and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable atrial-fibrillation
Started Nov 2015
Longer than P75 for not_applicable atrial-fibrillation
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 3, 2015
CompletedFirst Posted
Study publicly available on registry
November 11, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2030
April 26, 2022
April 1, 2022
14.2 years
November 3, 2015
April 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in quality of life as measured by the Short-Form 36 questionnaire
Change in quality of life from baseline to 12 weeks as measured by the Short Form-36 questionnaire.
baseline to 12 weeks
Change in exercise capacity as measured by six-minute walk test distance
Change in exercise capacity from baseline to 12 weeks as measured by six-minute walk test distance.
baseline to 12 weeks
Secondary Outcomes (12)
Change in exercise adherence measured by accelerometer
baseline to 12 weeks
Change in activity status measured by the Duke Activity Status Index
baseline to 12 weeks
Change in symptom burden measured by the Canadian Cardiovascular Society Severity of Atrial Fibrillation scale
baseline to 12 weeks
Change in symptom frequency and severity measured using the 7-day symptom diary
baseline to 12 weeks
Change in disease specific quality of life will be measured using the University of Toronto Atrial Fibrillation Severity Scale (AFSS)
baseline to 12 weeks
- +7 more secondary outcomes
Study Arms (2)
Moderate-intensity continuous exercise
EXPERIMENTALModerate-intensity continuous exercise training
High-Intensity Interval Training
EXPERIMENTALHigh-Intensity Interval Training
Interventions
Participants will complete supervised exercise sessions. Moderate-intensity continuous exercise training will follow cardiovascular rehabilitation guidelines. Participants will attend on-site moderate-intensity continuous exercise training two times weekly for 12 weeks.
Participants will complete supervised exercise sessions. Participants will attend on-site high-intensity interval training two times weekly for 12 weeks.
Eligibility Criteria
You may qualify if:
- persistent or permanent atrial fibrillation;
- rate controlled with a resting ventricular rate of equal to or less than 110 bpm;
- able to perform a symptom-limited exercise test;
- at least 40 years of age;
- patient agrees to sign informed consent.
You may not qualify if:
- currently participating in routine exercise training (more than two times per week);
- unstable angina;
- uncontrolled diabetes mellitus;
- diagnosed severe mitral or aortic stenosis;
- diagnosed hypertrophic obstructive cardiomyopathy with significant obstruction;
- unable to provide written, informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Ottawa Heart Insititue
Ottawa, Ontario, K1Y 4W7, Canada
Related Publications (1)
Reed JL, Terada T, Vidal-Almela S, Tulloch HE, Mistura M, Birnie DH, Wells GA, Nair GM, Hans H, Way KL, Chirico D, O'Neill CD, Pipe AL. Effect of High-Intensity Interval Training in Patients With Atrial Fibrillation: A Randomized Clinical Trial. JAMA Netw Open. 2022 Oct 3;5(10):e2239380. doi: 10.1001/jamanetworkopen.2022.39380.
PMID: 36315143DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer L Reed, PhD
Ottawa Heart Institute Research Corporation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2015
First Posted
November 11, 2015
Study Start
November 1, 2015
Primary Completion (Estimated)
January 1, 2030
Study Completion (Estimated)
October 1, 2030
Last Updated
April 26, 2022
Record last verified: 2022-04